Who Is at Risk for New Hepatitis B Infections Among People With HIV?

Sladic, John M; Taylor, Barbara S; Thamer, Mae; Vigil, Karen J; Kshirsagar, Onkar; Taranova, Anna; McCracken, Andrew; Sanchez, Carmen G; Jain, Mamta K

Sladic, John M; Taylor, Barbara S; Thamer, Mae; Vigil, Karen J; Kshirsagar, Onkar; Taranova, Anna; McCracken, Andrew; Sanchez, Carmen G; Jain, Mamta K.

Afiliação

Sladic JM; University of Texas Health Science Center, San Antonio, Texas, USA.
Taylor BS; University of Texas Health Science Center, San Antonio, Texas, USA.
Thamer M; Medical Technology and Practice Patterns Institute, Bethesda, Maryland, USA.
Vigil KJ; University of Texas Health Science Center, Houston, Texas, USA.
Kshirsagar O; Medical Technology and Practice Patterns Institute, Bethesda, Maryland, USA.
Taranova A; University of Texas Health Science Center, San Antonio, Texas, USA.
McCracken A; University of Texas Health Science Center, San Antonio, Texas, USA.
Sanchez CG; University Health, San Antonio, Texas, USA.
Jain MK; UT Southwestern Medical Center, Dallas, Texas, USA.

Open Forum Infect Dis ; 10(8): ofad375, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37539064

ABSTRACT

ABSTRACT

Hepatitis B virus (HBV) increases morbidity and mortality among people with HIV (PWH). We retrospectively analyzed HBV incidence among 5785 PWH. Fourteen had newly positive hepatitis B s antigen (mean 5.2 person-years of follow-up, 46.4/100 000 infections/year). These data show gaps in HBV vaccination and in the preventative efficacy of HBV-specific antiretroviral therapy.

Palavras-chave

HBV; HBV vaccination; HIV; incident HBV infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google